GADD45G antibody (N-Term)
Quick Overview for GADD45G antibody (N-Term) (ABIN952425)
Target
See all GADD45G AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 1-30, N-Term
-
Specificity
- This antibody recognizes Human GADD45G (N-term).
-
Purification
- Protein A column, followed by peptide affinity purification
-
Immunogen
- KLH conjugated synthetic peptide between 1-30 amino acids from the N-terminal region of human GADD45G
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- GADD45G (Growth Arrest and DNA-Damage-Inducible, gamma (GADD45G))
-
Alternative Name
- GADD45G
-
Background
- This gene is a member of a group of genes whose transcript levels are increased following stressful growth arrest conditions and treatment with DNA-damaging agents. The protein encoded by this gene responds to environmental stresses by mediating activation of the p38/JNK pathway via MTK1/MEKK4 kinase. The GADD45G is highly expressed in placenta.Synonyms: CR6, Cytokine-responsive protein CR6, DDIT2, DNA-damage-inducible transcript 2, Growth arrest and DNA-damage-inducible protein GADD45 gamma
-
Molecular Weight
- 17121 Da
-
Gene ID
- 10912
-
NCBI Accession
- NP_006696
-
Pathways
- Cell Division Cycle
Target
-